199 related articles for article (PubMed ID: 27638130)
1. Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain.
Thirunavukkarasu K; Swearingen CA; Oskins JL; Lin C; Bui HH; Jones SB; Pfeifer LA; Norman BH; Mitchell PG; Chambers MG
Osteoarthritis Cartilage; 2017 Jun; 25(6):935-942. PubMed ID: 27638130
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain.
McDougall JJ; Albacete S; Schuelert N; Mitchell PG; Lin C; Oskins JL; Bui HH; Chambers MG
Osteoarthritis Cartilage; 2017 Jun; 25(6):926-934. PubMed ID: 27651153
[TBL] [Abstract][Full Text] [Related]
3. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis.
Thirunavukkarasu K; Tan B; Swearingen CA; Rocha G; Bui HH; McCann DJ; Jones SB; Norman BH; Pfeifer LA; Saha JK
J Pharmacol Exp Ther; 2016 Oct; 359(1):207-14. PubMed ID: 27516465
[TBL] [Abstract][Full Text] [Related]
5. Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.
Joncour A; Desroy N; Housseman C; Bock X; Bienvenu N; Cherel L; Labeguere V; Peixoto C; Annoot D; Lepissier L; Heiermann J; Hengeveld WJ; Pilzak G; Monjardet A; Wakselman E; Roncoroni V; Le Tallec S; Galien R; David C; Vandervoort N; Christophe T; Conrath K; Jans M; Wohlkonig A; Soror S; Steyaert J; Touitou R; Fleury D; Vercheval L; Mollat P; Triballeau N; van der Aar E; Brys R; Heckmann B
J Med Chem; 2017 Sep; 60(17):7371-7392. PubMed ID: 28731719
[TBL] [Abstract][Full Text] [Related]
6. Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis.
Mapp PI; Sagar DR; Ashraf S; Burston JJ; Suri S; Chapman V; Walsh DA
Osteoarthritis Cartilage; 2013 Sep; 21(9):1336-45. PubMed ID: 23973148
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis.
Uranbileg B; Ito N; Kurano M; Kano K; Uchida K; Sumitani M; Aoki J; Yatomi Y
Sci Rep; 2021 Feb; 11(1):3984. PubMed ID: 33597645
[TBL] [Abstract][Full Text] [Related]
8. Effects of Treadmill Exercise on Advanced Osteoarthritis Pain in Rats.
Allen J; Imbert I; Havelin J; Henderson T; Stevenson G; Liaw L; King T
Arthritis Rheumatol; 2017 Jul; 69(7):1407-1417. PubMed ID: 28320059
[TBL] [Abstract][Full Text] [Related]
9. Altered activity of lysophospholipase D, which produces bioactive lysophosphatidic acid and choline, in serum from women with pathological pregnancy.
Tokumura A; Kume T; Taira S; Yasuda K; Kanzaki H
Mol Hum Reprod; 2009 May; 15(5):301-10. PubMed ID: 19297419
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin inhibitors: a patent review (2012-2016).
Nikolaou A; Kokotou MG; Limnios D; Psarra A; Kokotos G
Expert Opin Ther Pat; 2017 Jul; 27(7):815-829. PubMed ID: 28447479
[TBL] [Abstract][Full Text] [Related]
11. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
[TBL] [Abstract][Full Text] [Related]
13. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
Orosa B; García S; Conde C
Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
[TBL] [Abstract][Full Text] [Related]
14. A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension.
Saga H; Ohhata A; Hayashi A; Katoh M; Maeda T; Mizuno H; Takada Y; Komichi Y; Ota H; Matsumura N; Shibaya M; Sugiyama T; Nakade S; Kishikawa K
PLoS One; 2014; 9(4):e93230. PubMed ID: 24747415
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin inhibitors: a patent review.
Barbayianni E; Magrioti V; Moutevelis-Minakakis P; Kokotos G
Expert Opin Ther Pat; 2013 Sep; 23(9):1123-32. PubMed ID: 23641951
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid production from lysophosphatidylcholine by lysophospholipase D activity of autotaxin in plasma of women with normal and adverse pregnancies.
Tsutsumi T; Yasuda K; Neya M; Okada H; Tokumura A
Prostaglandins Other Lipid Mediat; 2022 Dec; 163():106670. PubMed ID: 35963509
[TBL] [Abstract][Full Text] [Related]
17. Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain.
Huang J; Burston JJ; Li L; Ashraf S; Mapp PI; Bennett AJ; Ravipati S; Pousinis P; Barrett DA; Scammell BE; Chapman V
Arthritis Rheumatol; 2017 May; 69(5):996-1008. PubMed ID: 27860453
[TBL] [Abstract][Full Text] [Related]
18. Monosodium iodoacetate-induced inflammation and joint pain are reduced in TRPA1 deficient mice--potential role of TRPA1 in osteoarthritis.
Moilanen LJ; Hämäläinen M; Nummenmaa E; Ilmarinen P; Vuolteenaho K; Nieminen RM; Lehtimäki L; Moilanen E
Osteoarthritis Cartilage; 2015 Nov; 23(11):2017-26. PubMed ID: 26521748
[TBL] [Abstract][Full Text] [Related]
19. Distinct contributions of two choline-producing enzymatic activities to lysophosphatidic acid production in human amniotic fluid from pregnant women in the second trimester and after parturition.
Fukui M; Tsutsumi T; Yamamoto-Mikami A; Morito K; NaokoTakahashi ; Tanaka T; Iwasa T; Kuwahara A; Irahara M; Tokumura A
Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106471. PubMed ID: 32585250
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a pipemidic acid autotaxin inhibitor.
Hoeglund AB; Bostic HE; Howard AL; Wanjala IW; Best MD; Baker DL; Parrill AL
J Med Chem; 2010 Feb; 53(3):1056-66. PubMed ID: 20041668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]